小分子抑制剂的葡萄糖载体的小分子抑制剂
Makoto Kawatani1, Hiroyuki Osada2
1Chemical Resource Development Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science (CSRS), Wako-shi, Saitama, Japan; Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science (CSRS), Wako-shi, Saitama, Japan.
Vitamins and hormones
|March 17, 2025
概括
针对促进性葡萄糖载体 (GLUT) 的小分子抑制剂在癌症治疗中表现有前途. 这些化合物,包括天然产品和合成分子,为理解和治疗依赖葡萄糖代谢的瘤提供了新的途径.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 由SLC2A基因编码的促进性葡萄糖转运体 (GLUTs) 对细胞糖吸收至关重要.
- GLUT异型,特别是GLUT1和GLUT3,在各种癌症中经常过度表达,与患者预后不佳相关.
- 异常的细胞能量代谢,包括高血糖分解,是人类癌症的标志.
研究的目的:
- 为提供小分子GLUT抑制剂的全面概述.
- 突出其作为研究瘤代谢的生物探针的潜力.
- 讨论它们在癌症治疗中的治疗应用.
主要方法:
- 对GLUT抑制剂的现有文献的综述.
- GLUT家族成员及其抑制剂的分类.
- 讨论基于结构的药物设计和高通量选方法.
- 自然产品,自然产品灵感的化合物和合成分子的分析.
主要成果:
- 几种GLUT异型在瘤中过度表达,这与不良的临床结果有关.
- 小分子GLUT抑制剂,包括黄类药物,可以阻碍葡萄糖的吸收.
- 已开发出强效和选择性的GLUT抑制剂,准糖解成的瘤.
- 澄清GLUT晶体结构有助于识别异型特异性抑制剂.
结论:
- 小分子GLUT抑制剂代表了癌症治疗的有希望的策略.
- 这些抑制剂是解剖复杂瘤代谢途径的宝贵工具.
- 进一步开发GLUT抑制剂可能会导致新型抗癌药物.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
139
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
139
Glucose Transporters
22.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.3K
Glucose Absorption Into the Small Intestine
31.1K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
148
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
148
Dipeptidyl Peptidase 4 Inhibitors
148
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
148
Secondary Active Transport
6.7K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
6.7K


